|  | Total (n = 83) | L + (n = 46) | L - (n = 37) | p-value (Test) | |||
---|---|---|---|---|---|---|---|---|
 |  | n | % | n | % | n | % |  |
Nodal status | N+ | 50 | 60.2 | 34 | 73.9 | 16 | 43.2 | 0.0066 (F) |
 | N- | 33 | 39.9 | 12 | 26.1 | 21 | 56.8 | ** |
Tumor size | T1 | 39 | 47 | 16 | 34.8 | 23 | 62.2 | 0.0159 (F) |
 | >T1 | 44 | 53 | 30 | 65.2 | 14 | 37.8 | * |
Grading | G1 | 3 | 3.6 | 0 | 0 | 3 | 8.1 | 0.9593 (M) |
 | G2 | 39 | 47 | 24 | 52.2 | 15 | 40.5 | n.s. |
 | G3 | 41 | 49.4 | 22 | 47.8 | 19 | 51.4 |  |
c-erB-2 | Her+ | 18 | 21.7 | 12 | 26.1 | 6 | 16.2 | 0.3005 (F) |
 | Her- | 65 | 78.3 | 34 | 73.9 | 31 | 83.8 | n.s. |
Estrogen receptor | ER+ | 60 | 72.3 | 33 | 71.7 | 27 | 73 | 1.0 (F) |
 | ER- | 23 | 27.7 | 13 | 28.3 | 10 | 27 | n.s. |
Progesterone receptor | PR+ | 51 | 61.5 | 26 | 56.5 | 25 | 67.6 | 0.3673 (F) |
 | PR- | 32 | 38.5 | 20 | 43.5 | 12 | 32.4 | n.s. |
Nuclear positivity | NUC+ | 24 | 29 | 20 | 43.5 | 4 | 11 | 0.0014 (F) |
 | NUC- | 59 | 71 | 26 | 56.5 | 33 | 89 | ** |